AgraFlora Organics Reports Farmako GmbH Obtains Drug License In UK

AgraFlora Organics International Inc. AGRA AGFAF disclosed Thursday that Farmako GmbH via its subsidiary Farmako Limited has obtained its Home Office Controlled Drug License.

Farmako Limited received the license in less than one month after the examination by the UK Home Office in December was successfully finalized.

With the new license, Farmako Limited plans to start wholesaling medical cannabis in the UK by the middle of 2020, counting on the imports of Bedrocan products from the Netherlands.

“The UK medicinal cannabis market has been estimated to reach US$1.3 billion by 2024, with up to 1% of the UK’s population expected to be eligible to receive medicinal cannabis prescriptions by 2028¹,” Katrin Eckmans, CEO of Farmako, said in a statement.

“Obtaining the License is a key milestone for our European business, positioning Farmako Limited as an early leader in the rapidly developing UK medicinal cannabis market.”

AgraFlora expects for the license coupled with broad National Health Service insurance coverage to be the crucial strategic component of its global cannabis revenue-generating trading platform.

Analyst: New UK Cannabis Regulations Limit Usage, Call For Additional Research

Market News and Data brought to you by Benzinga APIs

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

The Benzinga Cannabis Capital Conference is coming to Florida